Geode Capital Management LLC Has $5.67 Million Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

Geode Capital Management LLC lessened its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 0.3% during the third quarter, Holdings Channel reports. The institutional investor owned 772,808 shares of the company’s stock after selling 2,673 shares during the quarter. Geode Capital Management LLC’s holdings in Viemed Healthcare were worth $5,666,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of VMD. Wasatch Advisors LP raised its holdings in Viemed Healthcare by 19.6% during the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock worth $13,552,000 after acquiring an additional 303,277 shares in the last quarter. Apis Capital Advisors LLC raised its stake in shares of Viemed Healthcare by 193.0% during the 2nd quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock worth $1,535,000 after purchasing an additional 154,400 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Viemed Healthcare by 50.9% in the 2nd quarter. Renaissance Technologies LLC now owns 438,700 shares of the company’s stock valued at $2,873,000 after buying an additional 147,900 shares during the last quarter. Victory Capital Management Inc. grew its stake in shares of Viemed Healthcare by 748.2% in the third quarter. Victory Capital Management Inc. now owns 108,497 shares of the company’s stock valued at $795,000 after buying an additional 95,706 shares in the last quarter. Finally, Paradigm Capital Management Inc. NY increased its holdings in Viemed Healthcare by 25.0% during the second quarter. Paradigm Capital Management Inc. NY now owns 400,000 shares of the company’s stock worth $2,620,000 after buying an additional 80,000 shares during the last quarter. Institutional investors own 74.24% of the company’s stock.

Insider Transactions at Viemed Healthcare

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total transaction of $336,502.08. Following the transaction, the director now owns 107,706 shares in the company, valued at $999,511.68. This represents a 25.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Nitin Kaushal sold 5,995 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total value of $51,437.10. Following the completion of the transaction, the director now directly owns 126,843 shares of the company’s stock, valued at approximately $1,088,312.94. This trade represents a 4.51 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 72,256 shares of company stock worth $674,739. 20.00% of the stock is owned by company insiders.

Viemed Healthcare Stock Performance

Shares of VMD stock opened at $8.12 on Friday. The company has a fifty day moving average price of $8.60 and a two-hundred day moving average price of $7.82. Viemed Healthcare, Inc. has a one year low of $6.21 and a one year high of $10.44. The stock has a market cap of $316.17 million, a P/E ratio of 30.07 and a beta of 1.46. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Viemed Healthcare (NASDAQ:VMD) last issued its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. The business had revenue of $58.00 million during the quarter. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.